Connor, Clark & Lunn Investment Management (CC&L)
KERX

Connor, Clark & Lunn Investment Management (CC&L)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-121,499
Closed -$2.29M – 681
2014
Q1 		$2.29M Sell
121,499
-12,201
-9% -$229K 0.02% 262
2013
Q4 		$1.84M Sell
133,700
-12,100
-8% -$167K 0.01% 275
2013
Q3 		$1.51M Buy
+145,800
New +$1.51M 0.01% 226